Guangzhou Dengpingou Electronic Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Dengpingou Electronic Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include TYRNIX and TYRNIXEL. The owner is based in Guangzhou.
Room D068, Building 2,
No. 1 Hezheng Street, Baiyun District,
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Dengpingou Electronic Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Guangzhou Dengpingou Electronic Technology Co., Ltd. have?
Guangzhou Dengpingou Electronic Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Guangzhou Dengpingou Electronic Technology Co., Ltd. file in?
Guangzhou Dengpingou Electronic Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Guangzhou Dengpingou Electronic Technology Co., Ltd.'s most well-known trademarks?
Guangzhou Dengpingou Electronic Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as TYRNIX and TYRNIXEL. These are among 2 currently registered trademarks in the portfolio.
What is Guangzhou Dengpingou Electronic Technology Co., Ltd.'s trademark registration success rate?
Guangzhou Dengpingou Electronic Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.